Insiders · CNCE

Nancy Stuart

Officer at Concert Pharmaceuticals, Inc. (CNCE)

Nancy Stuart has filed 13 insider reports with the SEC since February 2021, as director at KalVista Pharmaceuticals, Inc. (KALV) and officer at Concert Pharmaceuticals, Inc. (CNCE). Nancy Stuart made no open-market purchases or sales in the last 12 months. The latest filing, on October 2, 2025, reports grant or award at KalVista Pharmaceuticals, Inc. (KALV).

Filings
13
Companies
2
Bought on market
None
Sold on market
$254K

Companies where Nancy Stuart is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
KalVista Pharmaceuticals, Inc. logo
KALV
KalVista Pharmaceuticals, Inc.
Directorsince March 2021Oct 2, 2025
Concert Pharmaceuticals, Inc. logo
CNCE
Concert Pharmaceuticals, Inc.
Officer262,596$254KFeb 16, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Nancy Stuart with

Other insiders at the same companies

Questions about Nancy Stuart

What is Nancy Stuart's role at Concert Pharmaceuticals, Inc.?
Nancy Stuart reports to the SEC as officer at Concert Pharmaceuticals, Inc. (CNCE), according to the latest filing on February 16, 2023. Nancy Stuart has also filed as director at KalVista Pharmaceuticals, Inc. (KALV).
How many shares does Nancy Stuart own?
After the latest filing that states it, Nancy Stuart directly owned 262,596 shares of Concert Pharmaceuticals, Inc. (CNCE). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Nancy Stuart bought or sold stock recently?
The most recent open-market sale was on February 15, 2023: sold 6,048 shares of Concert Pharmaceuticals, Inc. (CNCE) for $50.4K at an average of $8.33.
How do I get alerts when Nancy Stuart files?
Follow Nancy Stuart on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Nancy Stuart (SEC CIK 0001594774). Totals count each trade once, skipping amendments whose original is on file, from Feb 18, 2021 on. View on SEC EDGAR · Get this as JSON